PF
Pfizer Inc.
PFE.NE · NEO
$12.20 -1.21% (-$0.15)
1M +3.09%
Market Cap $148.8B
P/E Ratio 34.29x
Div. Yield 1.55%
ROE 4.90%
Bulios Fair Price
$17.5
43.4% upside
Trenutna cena
$12.2
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PFE.NE trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Strong
7/9Valuation
70 /100
Cheap P/FCF 13.39x
P/E 34.29x
P/B 1.75x
Growth
1 /100
Declining FCF growth 29.21%
EPS growth 9.71%
Book val. growth 3.37%
Profitability
89 /100
Strong Op. margin 26.27%
Gross margin 70.96%
FCF margin 17.25%
Quality
36 /100
Average ROA 2.16%
ROIC 10.25%
Asset turnover 0.32x
Debt
55 /100
Moderate Int. coverage 5.48x
Debt/Equity 0.74x
Net debt/EBITDA 2.89x
Stability
40 /100
Moderate EPS volatility 198.34%
Beta 0.42x
Profitable years 6
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PFE.NE
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Albert Bourla
Employees
75,000
Headquarters
New York City